GB201104897D0 - Method for the production of protein complexes and vaccine compositions comprising the same - Google Patents

Method for the production of protein complexes and vaccine compositions comprising the same

Info

Publication number
GB201104897D0
GB201104897D0 GBGB1104897.2A GB201104897A GB201104897D0 GB 201104897 D0 GB201104897 D0 GB 201104897D0 GB 201104897 A GB201104897 A GB 201104897A GB 201104897 D0 GB201104897 D0 GB 201104897D0
Authority
GB
United Kingdom
Prior art keywords
protein complexes
vaccine compositions
production
same
heat shock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1104897.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunobiology Ltd
Original Assignee
Immunobiology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd
Priority to GBGB1104897.2A priority Critical patent/GB201104897D0/en
Publication of GB201104897D0 publication Critical patent/GB201104897D0/en
Priority to US14/006,586 priority patent/US10240179B2/en
Priority to JP2014500473A priority patent/JP6009532B2/ja
Priority to AU2012232878A priority patent/AU2012232878A1/en
Priority to PCT/GB2012/050650 priority patent/WO2012127248A1/en
Priority to EP12710781.1A priority patent/EP2688589B1/en
Priority to BR112013024229A priority patent/BR112013024229A2/pt
Priority to CA2829678A priority patent/CA2829678C/en
Priority to CN2012800145739A priority patent/CN103458923A/zh
Priority to AU2017203173A priority patent/AU2017203173B2/en
Priority to US16/270,406 priority patent/US10669563B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001176—Heat shock proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB1104897.2A 2011-03-23 2011-03-23 Method for the production of protein complexes and vaccine compositions comprising the same Ceased GB201104897D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB1104897.2A GB201104897D0 (en) 2011-03-23 2011-03-23 Method for the production of protein complexes and vaccine compositions comprising the same
CN2012800145739A CN103458923A (zh) 2011-03-23 2012-03-23 用于产生蛋白复合物的方法和包含该蛋白复合物的疫苗组合物
PCT/GB2012/050650 WO2012127248A1 (en) 2011-03-23 2012-03-23 Method for the production of protein complexes and vaccine compositions comprising the same
JP2014500473A JP6009532B2 (ja) 2011-03-23 2012-03-23 タンパク質複合体及び該タンパク質複合体を含むワクチン組成物の生産方法
AU2012232878A AU2012232878A1 (en) 2011-03-23 2012-03-23 Method for the production of protein complexes and vaccine compositions comprising the same
US14/006,586 US10240179B2 (en) 2011-03-23 2012-03-23 Method for the production of protein complexes and vaccine compositions comprising the same
EP12710781.1A EP2688589B1 (en) 2011-03-23 2012-03-23 Method for the production of protein complexes and vaccine compositions comprising the same
BR112013024229A BR112013024229A2 (pt) 2011-03-23 2012-03-23 método para a produção de complexos de proteínas e composições de vacina compreendendo os mesmos
CA2829678A CA2829678C (en) 2011-03-23 2012-03-23 Method for the production of protein complexes and vaccine compositions comprising the same
AU2017203173A AU2017203173B2 (en) 2011-03-23 2017-05-12 Method For The Production Of Protein Complexes And Vaccine Compositions Comprising The Same
US16/270,406 US10669563B2 (en) 2011-03-23 2019-02-07 Method for the production of protein complexes and vaccine compositions comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1104897.2A GB201104897D0 (en) 2011-03-23 2011-03-23 Method for the production of protein complexes and vaccine compositions comprising the same

Publications (1)

Publication Number Publication Date
GB201104897D0 true GB201104897D0 (en) 2011-05-04

Family

ID=44013038

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1104897.2A Ceased GB201104897D0 (en) 2011-03-23 2011-03-23 Method for the production of protein complexes and vaccine compositions comprising the same

Country Status (9)

Country Link
US (2) US10240179B2 (https=)
EP (1) EP2688589B1 (https=)
JP (1) JP6009532B2 (https=)
CN (1) CN103458923A (https=)
AU (2) AU2012232878A1 (https=)
BR (1) BR112013024229A2 (https=)
CA (1) CA2829678C (https=)
GB (1) GB201104897D0 (https=)
WO (1) WO2012127248A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007285775B2 (en) * 2006-08-17 2011-03-03 Sanofi Pasteur Ltd. Immunogenic PcpA polypeptides and uses thereof
GB201104897D0 (en) * 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same
HK1207662A1 (en) * 2012-03-22 2016-02-05 AVITA Medical Americas, LLC Cell suspension and use thereof
CN108379553A (zh) * 2018-05-28 2018-08-10 上海市第人民医院 热休克蛋白20在氧化应激损伤疾病中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69228116T2 (de) * 1991-06-03 1999-05-20 Arch Development Corp., Chicago, Ill. Verfahren und zusammensetzungen des genetischen stressantwortsystems
US5961979A (en) 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
US5935576A (en) 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
GB9818133D0 (en) * 1998-08-19 1998-10-14 Quadrant Holdings Cambridge Vaccine
US6495360B1 (en) 1999-05-28 2002-12-17 Photogen, Inc. Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
GB9919734D0 (en) 1999-08-19 1999-10-20 Colaco Camilo Vaccines from infectious agents
GB9919733D0 (en) * 1999-08-19 1999-10-20 Colaco Camilo Vaccines against intracellular pathogens
KR100530911B1 (ko) 1999-10-01 2005-11-23 세이코 엡슨 가부시키가이샤 배선 기판, 반도체 장치 및 그 제조, 검사 및 실장 방법,회로 기판 및 전자 기기
GB0004547D0 (en) * 2000-02-23 2000-04-19 Immunobiology Ltd Screening method for novel vaccine candidates and compositions obtained thereby
GB0021757D0 (en) 2000-09-04 2000-10-18 Colaco Camilo Vaccine against microbial pathogens
WO2002028407A1 (en) 2000-09-29 2002-04-11 University Of Connecticut Health Center Methods of recovering heat shock proteins and complexes thereof
WO2009148608A1 (en) * 2008-06-03 2009-12-10 Bin Zhang Screening methods for heat-shock response modulators
GB0816242D0 (en) 2008-09-05 2008-10-15 Immunobiology Ltd Method of purifying protien complexes
GB0910591D0 (en) * 2009-06-19 2009-07-29 Immunobiology Ltd Method for the purification of protein complexes
GB0916557D0 (en) 2009-09-21 2009-10-28 Health Prot Agency Commensal neisserial stress protein complexes
GB201104897D0 (en) * 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same

Also Published As

Publication number Publication date
CA2829678C (en) 2019-07-09
US10669563B2 (en) 2020-06-02
JP2014510093A (ja) 2014-04-24
JP6009532B2 (ja) 2016-10-19
AU2017203173B2 (en) 2019-07-11
EP2688589A1 (en) 2014-01-29
CN103458923A (zh) 2013-12-18
WO2012127248A1 (en) 2012-09-27
CA2829678A1 (en) 2012-09-27
AU2012232878A1 (en) 2013-09-26
US10240179B2 (en) 2019-03-26
EP2688589B1 (en) 2017-05-17
US20190241923A1 (en) 2019-08-08
US20140017274A1 (en) 2014-01-16
AU2017203173A1 (en) 2017-07-27
BR112013024229A2 (pt) 2016-12-20

Similar Documents

Publication Publication Date Title
PH12017501445A1 (en) Methods for producing virus for vaccine production
TN2013000485A1 (en) 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
WO2012149546A3 (en) Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
MX2013004817A (es) Enfermedad inflamatoria.
TN2015000185A1 (en) 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
MX350795B (es) Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
EA201291195A1 (ru) Усовершенствованная терапия рака на основе опухолеассоциированных антигенов, полученных из циклина d1
UA113627C2 (xx) Кристалічна форма циклоспорину a, фармацевтична композиція та спосіб лікування
MX2013014485A (es) Vacuna bovinas y metodos.
MX2013012233A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas sustituidas.
PH12014501388A1 (en) A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv
PH12016501968A1 (en) Novel macrocyclic compounds
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
TN2015000186A1 (en) N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group
MX340536B (es) Terapia direccionada al receptor del factor de crecimiento epidermico (egfr).
GB201104897D0 (en) Method for the production of protein complexes and vaccine compositions comprising the same
MX344544B (es) Vacuna para paludismo en etapa sanguinea.
EA033027B1 (ru) Ослабленные вакцины от свиного гриппа и способы их получения и применения
MX367780B (es) Complejo inmunogénico para vacunación y método de obtención.
MX2015005111A (es) Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada.
BR112015000308A2 (pt) método para preparo de triazolopiridinas substituídas
MX363044B (es) Vacuna de virus de schmallenberg (sbv), metodos de produccion y sus usos.
WO2012059243A3 (en) Modulation of immune responses by the poxviral k4 protein
IN2015DN02772A (https=)
EP2686429A4 (en) COMPOSITIONS, PROCESS FOR PREPARING THESE COMPOSITIONS AND METHOD FOR TREATING INFLAMMATORY DISEASES

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)